60¢sixtycents

MAIA Biotechnology, Inc.MAIA

$1.40+0.08 (+6.06%)
AMEXHealthcare24:00 UTC

Company snapshot

Market Cap
$45M
Micro-cap
+14%
2022 — today
10-Year Price
-71%
2022 — today
52-Week Range
$0.87$2.95
Current $1.40· 25%

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

Valuation in context

P/E ratio
-2.0
N/A
Not meaningful — company is unprofitable
P/B ratio
1.6
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
-44.4%
Historically low
Historically low relative to the last 10 years
Free · No credit card needed

Get alerted when MAIA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.